Br J Pharmacol 179(4):557570 Tuttle KR, Lakshmanan MC, Rayner B, Busch RS, Zimmermann AG, Woodward DB et al (2018a) Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial
While the specific length of treatment depends on your plan with your doctor, it appears that GLP-1s should be used longterm to maintain weight loss
It can bring down swelling in the body
However, most studies that directly compare surgical versus medical weight loss are small, with heterogeneity of disease duration or severity limiting the statistical power
Preventive Health Optimization From a functional medicine perspective, early intervention with low-dose GLP-1s may help prevent the cascade of chronic conditions that stem from metabolic dysfunction
When we consume a wide variety of whole-food plants, lean proteins, and healthy fats, we support GLP-1 activity, optimize gut health, and can more easily maintain a healthy weight, Dr
